G55220VL

Summary
GlyTouCan ID
G55220VL
IUPAC Condensed
Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b1-
Motifs
N-Glycan high mannose
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1234.43
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
GlycoShape
Displaying 1 entry
Archetype α β
G00028MO
G58214IQ
G55220VL
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT1 UDP-GlcNAc
G55220VL
Asn-X
G08520NM
Asn-X
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT1 UDP-GlcNAc
G55220VL
Asn-X
G08520NM
Asn-X
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
POMGNT1 UDP-GlcNAc
G55220VL
pylidyramine
KEGG BRITE Database
KEGG ID
Enzyme
References
Reactions
Displaying all 2 entries
KEGG Reaction Enzyme Acceptor Product
R12479
R05983
GALAXY
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:a-dman-HEX-1:5
8b:a-dman-HEX-1:5
9b:a-dman-HEX-1:5
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:5o(6+1)7d
7:7o(3+1)8d
8:7o(6+1)9d
WURCS
WURCS=2.0/3,7,6/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5]/1-1-2-3-3-3-3/a4-b1_b4-c1_c3-d1_c6-e1_e3-f1_e6-g1
Literature
Displaying entries 1 - 10 of 80 in total
PubMed ID Title First Author Publication Date Source
35022400 Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues Williams SE 2022 Jan 12
  • GlyGen
33242084 Post-natal developmental changes in the composition of the rat neocortical N-glycome Klarić Thomas S 2021-06-03
  • GlyGen
33737529 Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures Suzuki Noriko 2021-03-18
  • GlyGen
34834161 Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity Cruz E 2021 Oct 20
  • GlyGen
  • PubChem
34106099 N-Glycosylation in isolated rat nerve terminals Matthies I 2021 Aug 1
  • GlyGen
33618028 Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry Moran AB 2021 Apr 30
  • GlyGen
  • PubChem
33889819 Aberrant sialylation in a patient with a HNF1alpha variant and liver adenomatosis Sturiale L 2021 Apr 23
  • GlyGen
33139572 Spatial and temporal diversity of glycome expression in mammalian brain Lee Jua 2020-11-17
  • GlyGen
31889402 Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment Schedin-Weiss Sophia 2020-08
  • GlyGen
33135055 Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 Shajahan A 2020 Oct 29
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025